ROYAL BANK OF CANADA - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$15,00019,025
+11865.4%
0.00%
Q2 2023$0159
+448.3%
0.00%
Q1 2023$0290.0%0.00%
Q4 2022$029
-66.7%
0.00%
Q3 2022$0870.0%0.00%
Q2 2022$0870.0%0.00%
Q1 2022$087
+3.6%
0.00%
Q4 2021$0
-100.0%
84
-97.2%
0.00%
Q1 2021$16,0000.0%3,0000.0%0.00%
Q4 2020$16,000
+60.0%
3,000
+200.0%
0.00%
Q2 2020$10,000
+66.7%
1,000
-48.6%
0.00%
Q1 2020$6,000
+100.0%
1,946
-36.3%
0.00%
Q4 2019$3,0000.0%3,054
+52.7%
0.00%
Q3 2019$3,000
-62.5%
2,0000.0%0.00%
Q2 2019$8,000
-20.0%
2,000
-8.9%
0.00%
Q1 2019$10,000
-16.7%
2,196
+9.8%
0.00%
Q4 2018$12,000
-14.3%
2,000
+100.0%
0.00%
Q3 2018$14,000
+16.7%
1,0000.0%0.00%
Q2 2018$12,000
+9.1%
1,000
-1.6%
0.00%
Q1 2018$11,0001,016
+1463.1%
0.00%
Q4 2017$0650.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
NEA Management Company, LLC 12,025,999$66,263,0002.30%
Abingworth LLP 250,000$1,375,0001.02%
Tekla Capital Management LLC 1,466,368$8,080,0000.31%
Rock Springs Capital Management LP 875,000$4,821,0000.28%
QVT Financial LP 1,360,647$6,940,0000.22%
Vident Investment Advisory, LLC 232,641$1,282,0000.13%
Hillhouse Capital Management 1,190,476$6,560,0000.13%
Orbimed Advisors 1,914,660$10,550,0000.12%
Granite Investment Partners, LLC 195,571$1,078,0000.07%
Monashee Investment Management LLC 25,000$138,0000.06%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders